Geoffrey Hall

1.6k total citations
30 papers, 1.2k citations indexed

About

Geoffrey Hall is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Geoffrey Hall has authored 30 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 8 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Geoffrey Hall's work include Ovarian cancer diagnosis and treatment (6 papers), Virus-based gene therapy research (5 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Geoffrey Hall is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Virus-based gene therapy research (5 papers) and Tissue Engineering and Regenerative Medicine (5 papers). Geoffrey Hall collaborates with scholars based in United Kingdom, Australia and United States. Geoffrey Hall's co-authors include Peter J. Selby, L M Wahl, J A Schmidt, L R Ellingsworth, Sharon M. Wahl, Anita B. Roberts, Suanne F. Dougherty, H.L.S. Wong, Nancy McCartney‐Francis and Jennifer Southgate and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Geoffrey Hall

29 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Geoffrey Hall United Kingdom	16	427	394	287	277	193	30	1.2k
Anna Maria Aglianò Italy	22	486 1.1×	654 1.7×	120 0.4×	250 0.9×	330 1.7×	43	1.3k
Pavel Strnad Czechia	22	256 0.6×	435 1.1×	152 0.5×	256 0.9×	155 0.8×	70	1.7k
Hélène LaRue Canada	25	740 1.7×	389 1.0×	351 1.2×	739 2.7×	153 0.8×	49	1.5k
Paulette Mhawech Switzerland	19	442 1.0×	247 0.6×	98 0.3×	335 1.2×	80 0.4×	33	1.2k
Jung‐Ta Chen Taiwan	20	538 1.3×	352 0.9×	192 0.7×	253 0.9×	246 1.3×	34	1.4k
Raquel Catarino Portugal	21	474 1.1×	584 1.5×	180 0.6×	129 0.5×	411 2.1×	68	1.2k
Frank Christoph Germany	24	944 2.2×	391 1.0×	110 0.4×	437 1.6×	308 1.6×	71	1.7k
Timothy J. O’Brien United States	21	522 1.2×	208 0.5×	318 1.1×	123 0.4×	147 0.8×	48	1.7k
Maria Monne Italy	17	628 1.5×	541 1.4×	249 0.9×	99 0.4×	248 1.3×	38	1.5k
Magdalena Kowalewska Poland	18	410 1.0×	314 0.8×	106 0.4×	222 0.8×	223 1.2×	45	1.1k

Countries citing papers authored by Geoffrey Hall

Since Specialization

Citations

This map shows the geographic impact of Geoffrey Hall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geoffrey Hall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geoffrey Hall more than expected).

Fields of papers citing papers by Geoffrey Hall

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geoffrey Hall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geoffrey Hall. The network helps show where Geoffrey Hall may publish in the future.

Co-authorship network of co-authors of Geoffrey Hall

This figure shows the co-authorship network connecting the top 25 collaborators of Geoffrey Hall. A scholar is included among the top collaborators of Geoffrey Hall based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geoffrey Hall. Geoffrey Hall is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheeseman, Sue, et al.. (2024). Evaluation of machine learning methods for the retrospective detection of ovarian cancer recurrences from chemotherapy data. SHILAP Revista de lepidopterología. 4. 100038–100038. 1 indexed citations

Pautier, Patricia, Ignace Vergote, Florence Joly, et al.. (2016). A Phase 2, Randomized, Open-Label Study of Irosustat Versus Megestrol Acetate in Advanced Endometrial Cancer. International Journal of Gynecological Cancer. 27(2). 258–266. 32 indexed citations

Collinson, Fiona, Rachel A. Craven, David A. Cairns, et al.. (2013). Predicting Response to Bevacizumab in Ovarian Cancer: A Panel of Potential Biomarkers Informing Treatment Selection. Clinical Cancer Research. 19(18). 5227–5239. 58 indexed citations

Pathmanathan, Nirmala, Pamela Provan, Hema Mahajan, et al.. (2012). Characteristics of HER2-positive breast cancer diagnosed following the introduction of universal HER2 testing. The Breast. 21(6). 724–729. 22 indexed citations

Wilson, Erica, Jehan J. El‐Jawhari, Geoffrey Hall, et al.. (2011). Human Tumour Immune Evasion via TGF-β Blocks NK Cell Activation but Not Survival Allowing Therapeutic Restoration of Anti-Tumour Activity. PLoS ONE. 6(9). e22842–e22842. 126 indexed citations

Harvey, Tracey J., I. Hennig, Steven D. Shnyder, et al.. (2011). Adenovirus-mediated hypoxia-targeted gene therapy using HSV thymidine kinase and bacterial nitroreductase prodrug-activating genes in vitro and in vivo. Cancer Gene Therapy. 18(11). 773–784. 16 indexed citations

Harvey, Tracey J., Lynette P. Steele, Nicola Ingram, et al.. (2010). Retargeted adenoviral cancer gene therapy for tumour cells overexpressing epidermal growth factor receptor or urokinase-type plasminogen activator receptor. Gene Therapy. 17(8). 1000–1010. 14 indexed citations

Ingram, Nicola, et al.. (2010). Role of cell surface molecules and autologous ascitic fluid in determining efficiency of adenoviral transduction of ovarian cancer cells. Cancer Gene Therapy. 17(10). 684–693. 3 indexed citations

Hall, Geoffrey, et al.. (2010). Immunohistochemistry for PMS2 and MSH6 alone can replace a four antibody panel for mismatch repair deficiency screening in colorectal adenocarcinoma. Pathology. 42(5). 409–413. 92 indexed citations

10.

Spencer, John, M.J. Weston, Samir Saidi, Nafisa Wilkinson, & Geoffrey Hall. (2010). Clinical utility of image-guided peritoneal and omental biopsy. Nature Reviews Clinical Oncology. 7(11). 623–631. 20 indexed citations

11.

Jackson, David, Rachel A. Craven, Richard Hutson, et al.. (2007). Proteomic Profiling Identifies Afamin as a Potential Biomarker for Ovarian Cancer. Clinical Cancer Research. 13(24). 7370–7379. 82 indexed citations

12.

Hall, Geoffrey, et al.. (2006). Image-guided biopsy in women with breast cancer presenting with peritoneal carcinomatosis. International Journal of Gynecological Cancer. 16. 108–110. 5 indexed citations

13.

Hall, Geoffrey, Robert J. Weeks, Jonathon Olsburgh, et al.. (2005). Transcriptional control of the human urothelial-specific gene, uroplakin Ia. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 1729(2). 126–134. 8 indexed citations

14.

Chester, John, Geoffrey Hall, Martin Förster, & Andrew Protheroe. (2004). Systemic chemotherapy for patients with bladder cancer – current controversies and future directions. Cancer Treatment Reviews. 30(4). 343–358. 35 indexed citations

15.

Chester, John, Wendy Kennedy, Geoffrey Hall, Peter J. Selby, & Margaret A. Knowles. (2003). Adenovirus-mediated gene therapy for bladder cancer: efficient gene delivery to normal and malignant human urothelial cells in vitro and ex vivo. Gene Therapy. 10(2). 172–179. 20 indexed citations

16.

Olsburgh, Jonathon, Patricia Harnden, Robert J. Weeks, et al.. (2002). Uroplakin gene expression in normal human tissues and locally advanced bladder cancer. The Journal of Pathology. 199(1). 41–49. 103 indexed citations

17.

Smith, Barbara A., Geoffrey Hall, Patricia Harnden, et al.. (1998). Uroplakin Gene Expression by Normal and Neoplastic Human Urothelium. American Journal Of Pathology. 153(6). 1957–1967. 102 indexed citations

18.

Joffe, Johnathan, Rosamonde E. Banks, M A Forbes, et al.. (1996). A phase II study of interferon‐α, interleukin‐2 and 5‐fluorouracil in advanced renal carcinoma: clinical data and laboratory evidence of protease activation. British Journal of Urology. 77(5). 638–649. 57 indexed citations

19.

Wahl, Sharon M., H.L.S. Wong, Suanne F. Dougherty, et al.. (1988). Transforming growth factor- beta is a potent immunosuppressive agent that inhibits IL-1-dependent lymphocyte proliferation.. The Journal of Immunology. 140(9). 3026–3032. 328 indexed citations

20.

Schmid, E., et al.. (1972). Die cytogenetische wirkung von blei in menschlichen peripheren lymphocyten in vitro und in vivo. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. 16(4). 401–406. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact